RIPK1 and central nervous system cancer: One study found that osthole is a potential drug for treating gliomas, as it increases the production of ROS and upregulates the expression of induced receptor interacting protein kinase 1 (RIP1), RIP2, and mixed lineage kinase domain-like protein (MLKL).